Resources and Insights

Slipstream Life Sciences Announces NIL Partnership with Amateur Golfer Miles Russell 

Blue Bell, PA – June 22, 2026 – Slipstream IT, a leading strategic technology partner to the life sciences industry, today…

Two FDA Policy Changes That Are Reshaping Drug Development 

In February 2026, the FDA made two announcements that will fundamentally change how drugs are developed, approved, and brought to…

Rare Disease Innovators

Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology

Blue Bell, PA – July 10, 2025 – Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud…

Emerging BiotechLarge Pharma

In-Housing Omnichannel Orchestration

Overview Life sciences companies are rethinking how they allocate capital and resources for omnichannel orchestration. Early investments prioritized speed: fully…

Emerging BiotechLarge Pharma

AI in Pharma: From Experimentation to Execution

Executive Summary The life sciences industry is at a critical inflection point. Artificial intelligence (AI) has rapidly evolved from experimentation…

Emerging BiotechLarge Pharma

Slipstream Announces New Investment from GreyLion Partners and Denali Growth Partners

BLUE BELL, Pa. – August 5, 2025–Slipstream IT (“Slipstream”), a trusted technology partner serving the pharmaceutical and biopharmaceutical industry, today announced…

Enterprise Clinical Data Modernization with DATAstream

Challenge Clinical data fragmentation across CROs, systems, and sources created operational bottlenecks. Clinical data originated from multiple vendors, EDC, RTSM,…

Emerging Biotech

Kickstarting Claims — Simple and Flexible Best Practices for Claim Review and Approval

Claims Out-of-Box For a long time now, the life sciences industry has been very interested in reaching a point where…

All-In-One: Using Portals for Accessing Approved Content in PromoMats and Medical Vaults

Introduction In recent years, I have noticed a shift in how life sciences companies prefer to provide their sales and…